Amgen, Cytokinetics and Servier Announce Topline Results From GALACTIC-HF, a Phase 3 Trial of Omecamtiv Mecarbil in Patients With Heart Failure

    NEXT STORY
    Global Active Pharmaceutical Ingredient Market (2020 to 2025) – Emerging Biosimilars Market Presents Opportunities
    PREV STORY
    Caladrius Biosciences Opens Study of CLBS119 to Repair COVID-19-Induced Lung Damage
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    BRACAnalysis CDx® Approved by U.S. Food and Drug Administration as Companion Diagnostic for AstraZeneca’s Lynparza® (olaparib) in Patients with Advanced-Stage, BRCA-Mutated Ovarian Cancer

    SALT LAKE CITY, Dec. 19, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), ...

    author_avatar
    NASDAQ Market News

    Valneva Reports H1 Results Marked by Major Corporate Achievements and Strong Cash Position

    author_avatar
    NASDAQ Market News

    Chembio Diagnostics to Report First Quarter 2020 Financial Results on May 4, 2020

    author_avatar
    NASDAQ Market News